Last update :
19/11/2024
References   References 4256  
Type : Journal
Web link : doi:10.3390/pharmaceutics11040190

Research teams : Poitiers - Centre Hospitalier Universitaire de Poitiers
Authors : Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A.
Title : Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients.
Reference : Pharmaceutics ;11,190: 2019

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
Oral solutionDexamethasone acetate Anti-inflammatory
Stability in solutions Glass powder 100 mg
® = ?
SyrSpend SF PH4® Dry 1,3g
Water for injection >> 20 mL
18-26°C Protect from light
60 Day
Stability in solutions Glass powder 100 mg
® = ?
SyrSpend SF PH4® Dry 1,3g
Water for injection >> 20 mL
2-8°C Protect from light
60 Day
Oral solutionHydrochlorothiazide Diuretic
Stability in solutions Glass powder 40 mg
® = ?
SyrSpend SF PH4® Dry 1,3g
Water for injection >> 20 mL
18-26°C Protect from light
60 Day
Stability in solutions Glass powder 40 mg
® = ?
SyrSpend SF PH4® Dry 1,3g
Water for injection >> 20 mL
2-8°C Protect from light
60 Day
Oral solutionPhenytoin Antiepileptic
Stability in solutions Glass powder 100 mg
® =?
SyrSpend SF PH4® Dry 1,3 g
Water for injection >> 20 mL
18-26°C Protect from light
60 Day
Stability in solutions Glass powder 100 mg
® =?
SyrSpend SF PH4® Dry 1,3 g
Water for injection >> 20 mL
2-8°C Protect from light
60 Day
Oral solutionSpironolactone Diuretic
Stability in solutions Glass powder 100 mg
® = ?
SyrSpend SF PH4® Dry 1,3 g
Water for injection >> 20 mL
18-26°C Protect from light
60 Day
Stability in solutions Glass powder 100 mg
® = ?
SyrSpend SF PH4® Dry 1,3 g
Water for injection >> 20 mL
2-8°C Protect from light
60 Day

  Mentions Légales